GET DETAILED INFORMATION

Thanks for submitting!

Disclaimer: For Medical & Research Professionals Only

This website is intended to inform and educate medical professionals and researchers. It is NOT intended for patients. It also does not seek to make claims about the effectiveness of regenerative medicine and its respective therapies in medical treatment.

Regenerative therapies have great potential in helping treat a range of conditions. This site serves to inform medical professionals about regenerative medicine, Regenerelle Umbilical Cord derived products, and key in vitro, animal model, and clinical research studies that have been carried out to date across medical specialties and health conditions. However, regenerative medicine is an early and evolving field, and clinical studies are still insufficient to determine effectiveness.

While the Regenerelle regenerative products are produced in an FDA compliant laboratory, it has not been approved by the FDA for treatment effectiveness. The FDA states:

Like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood-forming stem cells) for certain indications.

Patients interested in regenerative therapy in the U.S. are advised to consult a physician about the state of FDA approval for any given product and/or inquire about opportunities to participate in a clinical trials and FDA Expanded Access IND Individual or Group Treatment Trials. Patients interested in regenerative therapies outside the U.S. should investigate regulations in the specific country. It is important to be aware that regulations and clinical study requirements vary from country to country.

By signing up you confirm that you are a medical professional or researcher and, understand that the information contained in this website is intended for medical professionals and researchers and not for the general public, and have read and understood the disclaimer above.